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Volume 60, Number 5 Abstracts 1407Results: Between 2005 and 2013, nine patients (3%) with malignant
lower extremity STS underwent surgical resection with vascular reconstruc-
tion. Of these, 6 (67%) underwent resection of femoral and popliteal vessels
with subsequent femoropopliteal bypass, 1 (11%) underwent resection of
femoral vessels with iliac-SFA bypass, 1 (11%) underwent transection of
the femoral and popliteal vessels with reanastomosis, and 1 (11%) under-
went resection of the superﬁcial femoral vessels with superﬁcial femoral ar-
tery-distal superﬁcial femoral artery bypass. All bypasses were performed
using saphenous vein from the contralateral leg. Four patients (44%)
returned to the operating room for wound complications requiring incision
and drainage. Three (33%) required plastic surgery each for one of the
following: VRAM ﬂap, split-thickness skin graft, and pedicle gracilis ﬂap.
Functional activity was assessed using the criterion 1 of the Musculoskeletal
Tumor Society (MSTS) functional assessment forms preoperatively and at
follow-up at 6 months and 1 year. A score of 5 indicates no functional re-
strictions, whereas a score of 0 indicates total disability. The mean MSTS
scores preoperatively and at 6 months and 1 year were 4.1, 3.6, and 3.8,
respectively, for the vascular reconstruction group, and 4.2, 4.3, and 4.3,
respectively, for the limb-sparing surgery without vascular reconstruction
group.
Conclusions: The need for vascular reconstruction during limb-
sparing surgery for lower extremity malignant STS is rare in a high-volume
sarcoma center. Wound morbidity is high, and these patients frequently
require plastic surgery to achieve wound healing. Postoperative functional
status as assessed by the MSTS is acceptable but may be lower than in pa-
tients not requiring vascular reconstruction.
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Objectives: The purpose of this study was to determine the toe-
brachial index (TBI) in healthy young adults and compare it with the
accepted reference range.
Methods: Medical students from the undergraduate class were pro-
spectively recruited. Physical measurements (height, weight), health behav-
iors (physical activity quantity and type, smoking status, alcohol
consumption), and medical history (medications, relevant diagnoses, family
history) were collected. Bilateral brachial, toe, and ankle blood pressures
(using both dorsalis pedis and posterior tibial arteries) were measured.
TBI was calculated as the mean toe blood pressure divided by the highest
systolic brachial blood pressure.
Results: Forty medical students with a mean age of 24.7 6 2.1 years,
without any comorbid conditions, were studied. There were no current or
past smokers. Participants maintained relatively healthy lifestyles (hours of
activity per week: 5.1 6 3.3; body mass index: 21.7 6 2.4 kg/m2). Caffeine
and alcohol consumption was modest (10.6 6 8.5 and 1.8 6 2.7 drinks per
week, respectively). The mean systolic brachial blood pressure was 121 6
9 mm Hg (right), and 116 6 9 mm Hg (left). The TBI was 0.95 6 0.11
(right) and 0.97 6 0.13 (left) for men, and 0.86 6 0.13 (right) and 0.86
6 0.20 (left) for women.
Conclusions: The distribution of TBI in this healthy population dif-
fers signiﬁcantly from the referenced normal range of 0.6 to 1.0. Our ﬁnd-
ings suggest that the accepted value of 0.6 for the low-normal limit is too
low. This level may promote underdiagnosis of peripheral vascular disease
and represent foregone opportunities for early intervention. We recommend
that the TBI reference range be modiﬁed to increase the clinical utility of
this measurement.
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Vancouver, British Columbia, Canada*Principal Investigator.Objectives: The fastest growing segment of the dialysis population in
Canada is in patients aged >75 years, with an overall increase from 5% in
1980 to 28.2% in 2010. These patients present multiple signiﬁcant chal-
lenges to caregivers, including differences in life expectancy, comorbid
health status, goals of care, and supportive care requirements. The current
National Kidney Foundation Kidney Disease Outcomes Quality Initiative
guidelines do not take age into account in recommendations for hemodial-
ysis access. The goal of our study was to compare failure to mature, overall
survival, and complication rates for arteriovenous ﬁstulae in octogenarians
with nonoctogenarians to determine if our standard approach to renal access
should be modiﬁed to account for advanced age.
Methods: A review was conducted of all patients requiring arteriove-
nous ﬁstulae for hemodialysis access at two teaching hospitals between 2007
and 2012. The study was designed as a retrospective cohort study with pa-
tients stratiﬁed by age into octogenarians and nonoctogenarians. Data were
collected from a large, prospectively maintained database of all dialysis and
predialysis patients.
Results: Of 1019 patients who had their access created during the study
period andwere eligible for inclusion, 156 (15.3%) were aged$80 years at the
time of ﬁstula creation.With respect to the primary end point, therewas no dif-
ference betweenoctogenarians andnonoctogenarianswith respect to failure to
mature of the ﬁstula (38.7% vs 34.0%; P¼NS). Octogenarians had decreased
overall survival andwere signiﬁcantlymore likely to die during the study period
(45.8% vs 23.2%; P< .001). There were no signiﬁcant differences between the
two cohorts with respect to postoperative incidence of steal syndrome (7.3% vs
6.3%; P ¼ NS) or wound complications (5.3% vs 5.7%; P ¼ NS).
Conclusions: The results of this study demonstrate no overall differ-
ences in maturation rates within the octogenarian group and that age alone
should not preclude placement of an autogenous arteriovenous ﬁstula in this
cohort. These ﬁndings demonstrate that an approach that incorporates
limited life expectancy should be used when planning hemoaccess in this
growing demographic.
Author Disclosures: J. Misskey: Nothing to disclose. J. Faulds: Nothing
to disclose. Y. Hsiang: Nothing to disclose.
Suggestion of Better Outcomes With Two-Stage Brachiobasilic Vein
Transposition: A Meta-Analysis
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Objectives: Brachiobasilic vein transposition is recommended in pa-
tients who are not candidates for a radial or brachial artery-to-cephalic
vein ﬁstula for dialysis access. One-stage and two-stage procedures both
have advantages and disadvantages. Which procedure results in improved
outcomes remains unclear.
Methods: A systematic review was conducted of the MEDLINE and
EMBASE databases for studies that compared one-stage and two-stage bra-
chiobasilic vein transpositions. Abstracts and full texts of studies were
screened independently by two reviewers, with data abstraction done in
duplicate. Random-effects meta-analysis was used to identify differences in
primary failure rates and 1-year primary and secondary patency rates. Study
quality was assessed using a previously described tool designed for observa-
tional studies reporting on dialysis access outcomes.
Results: Of 1662 abstracts that were screened, 131 were selected for
full-text review.Of these, seven studies (one randomized trial, six observational
studies) involving 737 patients met the inclusion criteria. The pooled odds ra-
tio (OR) estimate for primary failure was 1.36 (95% conﬁdence interval [CI],
0.92-2.00), suggesting reduced failure rate in patients having undergone two-
stage transpositions, although thiswas not statistically signiﬁcant (Fig 1). Simi-
larly the estimated ORs of 1.71 (95% CI, 0.89-3.28) for the 1-year primary
patency rate and 1.44 (95% CI, 0.49-4.24) for the 1-year secondary patency
rate were in favor of the two-stage procedure, but again, the results were
nonsigniﬁcant (Fig 2). Study quality was limited by unclear outcome deﬁni-
tions,minimal control for confounding, and variable selection criteria. The de-
cision topursue one-stage vs two-stagewas often basedon the size of the basilic
vein, with a two-stage procedure reserved for patients with smaller veins.
Conclusions: Meta-analysis of the existing literature comparing one-
stage and two-stage brachiobasilic vein transposition suggests improved 1-
year patency and reduced primary failure rates in the two-stage group,
despite the two-stage procedure being used in patients with smaller basilic
veins. These ﬁndings are limited by the small size, observational design,
and inconsistent quality of included studies.
